Patents by Inventor Luping Chen

Luping Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACETYL COA CARBOXYLASE 2 SEQUENCES AND METHODS
    Publication number: 20080026363
    Abstract: The present invention relates generally to novel nucleotide and amino acid sequences, and more particularly to novel human acetyl CoA carboxylase 2 (ACC2) and rat ACC2 sequences. The sequences provided herein can be expressed in a recombinant format. Methods of isolating the ACC2 sequence are also provided, which can be employed to isolate any ACC sequence. The ACC2 sequences can be employed in therapeutic applications to diagnose or treat a condition associated with ACC2. The invention also relates to the identification of modulators of ACC activity using the recombinant human ACC2 enzyme as the screening target.
    Type: Application
    Filed: March 9, 2007
    Publication date: January 31, 2008
    Inventors: Dong Cheng, John Feder, Luping Chen, Ching-Hsuen Chu
  • ASSAY FOR MEASURING ACYLTRANSFERASE ACTIVITY
    Publication number: 20070292906
    Abstract: The subject matter disclosed and claimed herein relates to a high-throughput assay, and components thereof, for measuring the activity of acyltransferases. The high-throughput assay allows for rapid and accurate screening and identification of compounds that are modulators (e.g., inhibitors or activators) of acyltransferases, that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, and other diseases or disorders attributed to acyltransferase activity.
    Type: Application
    Filed: June 14, 2007
    Publication date: December 20, 2007
    Inventors: Dong Cheng, Luping Chen
  • Acetyl CoA carboxylase 2 sequences and methods
    Patent number: 7211423
    Abstract: The present invention relates generally to novel nucleotide and amino acid sequences, and more particularly to novel human acetyl CoA carboxylase 2 (ACC2) and rat ACC2 sequences. The sequences provided herein can be expressed in a recombinant format. Methods of isolating the ACC2 sequence are also provided, which can be employed to isolate any ACC sequence. The ACC2 sequences can be employed in therapeutic applications to diagnose or treat a condition associated with ACC2. The invention also relates to the identification of modulators of ACC activity using the recombinant human ACC2 enzyme as the screening target.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: May 1, 2007
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Dong Cheng, John N. Feder, Luping Chen, Ching-Hsuen Chu
  • Acetyl CoA carboxylase 2 sequences and methods
    Publication number: 20060019364
    Abstract: The present invention relates generally to novel nucleotide and amino acid sequences, and more particularly to novel human acetyl CoA carboxylase 2 (ACC2) and rat ACC2 sequences. The sequences provided herein can be expressed in a recombinant format. Methods of isolating the ACC2 sequence are also provided, which can be employed to isolate any ACC sequence. The ACC2 sequences can be employed in therapeutic applications to diagnose or treat a condition associated with ACC2. The invention also relates to the identification of modulators of ACC activity using the recombinant human ACC2 enzyme as the screening target.
    Type: Application
    Filed: July 21, 2005
    Publication date: January 26, 2006
    Inventors: Dong Cheng, John Feder, Luping Chen, Ching-Hsuen Chu
  • Coffee machine
    Patent number: D1012591
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: January 30, 2024
    Inventors: Jianping Xiao, Haobo Chen, Luping Chen